| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 10/10/2008 | 23:23 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AGIX | Atherogenics (MM) |
| 10/10/2008 | 23:15 | Marketwired | AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing | NASDAQ:AGIX | Atherogenics (MM) |
| 10/10/2008 | 21:35 | Edgar (US Regulatory) | Withdrawal of Registration Statement (RW) | NASDAQ:AGIX | Atherogenics (MM) |
| 07/10/2008 | 14:20 | Edgar (US Regulatory) | Atherogenics Inc - Current report filing (8-K) | NASDAQ:AGIX | Atherogenics (MM) |
| 07/10/2008 | 12:51 | Marketwired | AtheroGenics Files for Chapter 11 Bankruptcy | NASDAQ:AGIX | Atherogenics (MM) |
| 11/09/2008 | 01:13 | Marketwired | AtheroGenics Restructures Board of Directors | NASDAQ:AGIX | Atherogenics (MM) |
| 02/09/2008 | 17:44 | Marketwired | BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL | NASDAQ:AGIX | Atherogenics (MM) |
| 02/09/2008 | 14:39 | Marketwired | AtheroGenics Seeks to Realign Capital Structure | NASDAQ:AGIX | Atherogenics (MM) |
| 25/08/2008 | 21:00 | Edgar (US Regulatory) | Atherogenics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:AGIX | Atherogenics (MM) |
| 20/08/2008 | 12:24 | Edgar (US Regulatory) | Atherogenics Inc - Application for qualification of trust indentures (T-3) | NASDAQ:AGIX | Atherogenics (MM) |
| 05/08/2008 | 13:00 | Marketwired | AtheroGenics Reports Second Quarter 2008 Financial Results | NASDAQ:AGIX | Atherogenics (MM) |
| 01/08/2008 | 16:20 | PR Newswire (US) | BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD | NASDAQ:AGIX | Atherogenics (MM) |
| 31/07/2008 | 17:27 | Marketwired | BellwetherReport.com Analyst Report on HOLX, AKAM, SBUX and AGIX | NASDAQ:AGIX | Atherogenics (MM) |
| 31/07/2008 | 13:00 | Marketwired | AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes | NASDAQ:AGIX | Atherogenics (MM) |
| 25/07/2008 | 13:15 | Marketwired | AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008 | NASDAQ:AGIX | Atherogenics (MM) |
| 30/06/2008 | 15:21 | Marketwired | AtheroGenics Receives Notice of Non-Compliance With Listing Requirement for the NASDAQ Global Market | NASDAQ:AGIX | Atherogenics (MM) |
| 19/06/2008 | 15:20 | PR Newswire (US) | BeaconEquity.com Issues TraderNotes on Stocks: TPIM, NSM, BRLC, AGIX, AROX, TLEO, HLYS, ABAT | NASDAQ:AGIX | Atherogenics (MM) |
| 10/06/2008 | 15:17 | Marketwired | AtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association Ann | NASDAQ:AGIX | Atherogenics (MM) |
| 04/06/2008 | 13:30 | Marketwired | AtheroGenics Announces Five Abstracts Accepted for the American Diabetes Association's 68th Annual Scientific Sessions | NASDAQ:AGIX | Atherogenics (MM) |
| 23/05/2008 | 21:38 | Edgar (US Regulatory) | Atherogenics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGIX | Atherogenics (MM) |
| 23/05/2008 | 02:55 | Marketwired | AtheroGenics' ARISE Trial Results Published in The Lancet | NASDAQ:AGIX | Atherogenics (MM) |
| 09/05/2008 | 23:10 | Edgar (US Regulatory) | Atherogenics Inc - Quarterly Report (10-Q) | NASDAQ:AGIX | Atherogenics (MM) |
| 30/04/2008 | 20:51 | Marketwired | / CORRECTION - AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008 | NASDAQ:AGIX | Atherogenics (MM) |
| 30/04/2008 | 16:57 | Marketwired | AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008 | NASDAQ:AGIX | Atherogenics (MM) |
| 24/04/2008 | 13:00 | Marketwired | AtheroGenics Reports First Quarter 2008 Financial Results | NASDAQ:AGIX | Atherogenics (MM) |
| 18/04/2008 | 15:33 | Edgar (US Regulatory) | Atherogenics Inc - Proxy Statement (definitive) (DEF 14A) | NASDAQ:AGIX | Atherogenics (MM) |
| 17/04/2008 | 15:18 | Marketwired | AtheroGenics to Report First Quarter 2008 Financial Results on April 24, 2008 | NASDAQ:AGIX | Atherogenics (MM) |
| 14/04/2008 | 13:00 | Marketwired | AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes | NASDAQ:AGIX | Atherogenics (MM) |
| 07/04/2008 | 22:38 | Edgar (US Regulatory) | Atherogenics Inc - Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:AGIX | Atherogenics (MM) |
| 11/03/2008 | 14:31 | Marketwired | AtheroGenics to Present at Lehman Brothers Global Healthcare Conference March 18, 2008 | NASDAQ:AGIX | Atherogenics (MM) |